首页> 外国专利> Methods of in vivo engineering of large sequences using multiple CRISPR/cas selections of recombineering events

Methods of in vivo engineering of large sequences using multiple CRISPR/cas selections of recombineering events

机译:使用多个CRISPR / cas选择重组事件的大序列体内工程化方法

摘要

The present invention provides a method for making a large nucleic acid having a defined sequence in vivo. The method combines recombineering techniques with a CRISPR/Cas system to permit multiple insertions of defined sequences into a target nucleic acid at one time, double stranded cleavage of target nucleic acids in which the defined sequences were not successfully inserted, and selection of successful recombinant cells. The method further includes repeating the process one or more times, using a successful recombinant from one round as the host cell for the next round.
机译:本发明提供了一种在体内制备具有确定序列的大核酸的方法。该方法将重组技术与CRISPR / Cas系统相结合,可一次将定义的序列多次插入目标核酸中,将未成功插入定义的序列的目标核酸进行双链裂解,并选择成功的重组细胞。该方法进一步包括使用来自一轮的成功重组体作为下一轮的宿主细胞,重复该过程一次或多次。

著录项

  • 公开/公告号US10612043B2

    专利类型

  • 公开/公告日2020-04-07

    原文格式PDF

  • 申请/专利权人 AGILENT TECHNOLOGIES INC.;

    申请/专利号US201414773466

  • 发明设计人 CARSTEN-PETER CARSTENS;

    申请日2014-01-07

  • 分类号C12N15/90;C12N9/22;C12N15/85;

  • 国家 US

  • 入库时间 2022-08-21 11:27:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号